Immunoblotting and qRT-PCR data revealed that the levels of cell death markers and CAMs were changed following the treatment with PKC inhibitors, especially in the case of Rottlerin, in both colon epithelial and cancer cell lines. This evidence concerns the gene PRRT2 and cancer.